Latest Ratings for ALL
Date Firm Action From To Mar 2022 Goldman Sachs Maintains Buy Feb 2022 UBS Upgrades Neutral Buy Feb 2022 Raymond James Maintains Outperform
View More Analyst Ratings for ALL
View the Latest Analyst Ratings
Read the full story on Benzinga.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.